Overview

Louise’s background is in health technology assessment and evidence synthesis. Her interests have spread to health economics, having developed and critique a number of assessments to inform national decision-making for the National Institute for Health and Care Excellence (NICE), and locally for North East and West (NEW) Devon CCG, conducting rapid reviews as well as conducting budget impact analyses. Louise also has experience as a Senior Systematic Reviewer with the National Guidelines Alliance (Royal College of Obstetricians and Gynaecologists), contributing to the development of a number of NICE clinical guidelines.

Louise also has experience as a scientific writer with clinical trials and regulatory writing experience for GSK Vaccines for the meningococcal and chronic obstructive pulmonary disease (COPD) platforms, and has held positions as Head of Medical Writing at leading international medical communications agencies in the UK and Europe. She has also been involved in the production of a wide range of global and regional medical education materials. These have included peer-reviewed publications; meeting, marketing and training materials as well as information for patients. In addition, she has led the preparation of health technology assessment submissions for NICE, Scottish Medicines Consortium (SMC), National Centre for Pharmacoeconomics (NCPE) (Ireland), the National Health Care Institute (Zorginstituut Nederland [ZIN]), and the Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA]).

Qualifications

• BA (Hons) English Literature
• MSc Health Economics and Health Policy (Merit)

Back to top

Research

Research interests

• Evidence synthesis and systematic review
• Economic evaluation of health technologies
• Health technology assessment

Broad research specialisms:

Research interests and activities involve the use of economics and health economics principles to improve decision making in the health setting, and across related areas.

Research projects

• CEA in dementia and alzheimer’s disease

Grants/Funding:

Co-applicant:

• Five-year contract from the National Institute for Health Research (NIHR) Health Technology Assessment Programme (NIHR: £3.5 million)
• MRC Newton Fund grant. Collaboration with the Fundação Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro. Evaluation of the clinical and cost-effectiveness of diagnostic and therapeutic interventions for the treatment of hepatitis C: (total awarded not known) (~2014/2015)
• The best of the UK? A report on the value and future of UK databases in the health and social care fields: (£3,000) (year not known)
• Pain relief for venous cannulation of adults in routine treatment settings: a systematic review (£15,000) (~2011/2012)

Back to top

External Engagement and Impact

Committee/panel activities

• National Institute for Health and Care Excellence Early Scientific Advice
• National Institute for Health and Care Excellence Clinical Guidelines ad hoc committee member

Back to top

Teaching

• External:
  • British Association of Pharmaceutical Physicians (BrAPP) PostGraduate Course in Pharmaceutical Medicine Module (The Economics of Healthcare): Introduction to Health Economics and Health Technology Assessment (2017, 2018, and May 2019).

Modules

2023/24

• HPDM136 - Evidence to Decision: Health Technology Assessment, Health Policy and Resource Allocation
• HPDM136Z - Evidence to Decision: Health Technology Assessment, Health Policy and Resource Allocation

Back to top